DOCPLANET COM INC
10QSB, EX-27, 2000-08-23
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DOCPLANET COM INC, 10QSB, 2000-08-23
Next: BP AMOCO PLC, 6-K, 2000-08-23



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1

<S>                                     <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       AUG-31-2000
<PERIOD-START>                          SEP-01-1999
<PERIOD-END>                            AUG-31-2000
<CASH>                                     259,998
<SECURITIES>                                     0
<RECEIVABLES>                            1,634,856
<ALLOWANCES>                              (391,177)
<INVENTORY>                                728,859
<CURRENT-ASSETS>                         2,376,384
<PP&E>                                   4,025,543
<DEPRECIATION>                          (1,799,489)
<TOTAL-ASSETS>                           4,694,008
<CURRENT-LIABILITIES>                    6,323,545
<BONDS>                                          0
                      292,558
                                      0
<COMMON>                                37,209,008
<OTHER-SE>                               1,554,682
<TOTAL-LIABILITY-AND-EQUITY>             4,694,008
<SALES>                                  2,391,100
<TOTAL-REVENUES>                         2,391,100
<CGS>                                    1,972,064
<TOTAL-COSTS>                            1,972,064
<OTHER-EXPENSES>                         1,445,049
<LOSS-PROVISION>                           153,997
<INTEREST-EXPENSE>                         515,459
<INCOME-PRETAX>                         (1,695,469)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                     (1,695,469)
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                            (1,695,469)
<EPS-BASIC>                                (.230)
<EPS-DILUTED>                                (.230)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission